• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泌尿外科Cochrane系统评价共同发表文献的标准依从性和引用影响力。

Criteria adherence and citation impact of urologic Cochrane review co-publications.

作者信息

Vasdev Ranveer, Shakur Zahrah, Dahm Philipp

机构信息

School of Medicine University of Minnesota Twin Cities Minneapolis Minnesota USA.

Cochrane Urology Group Minneapolis Minnesota USA.

出版信息

Cochrane Evid Synth Methods. 2023 Mar 27;1(2):e12004. doi: 10.1002/cesm.12004. eCollection 2023 Apr.

DOI:10.1002/cesm.12004
PMID:40474915
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11795977/
Abstract

INTRODUCTION

Cochrane systematic reviews are widely recognized as authoritative sources of evidence. To improve dissemination and impact, editorial groups often encourage co-publication of their reviews in other journals. Our study aimed to analyze urology-relevant co-publications and determine their adherence to Cochrane's four co-publication criteria and impact using citation analysis.

METHODS

We systematically identified all Cochrane reviews published by the Urology, Incontinence, Renal, and Transplantation Groups from 1998 to 2021 as well as subsequent co-publications using MEDLINE, Web of Science, Scopus, and Google Scholar databases. We also determined adherence to Cochrane's four co-publication criteria and analyzed citation rates.

RESULTS

Of the 202 Cochrane reviews included, 52 (25.7%) had an associated co-publication. The majority of the co-publications corresponded to the Urology Group (39; 76.9%), followed by the Incontinence (9; 17.3%) and Kidney and Transplant Group (3; 5.8%). Only 21 (40.0%) co-publications met all four co-publication criteria, with the most common criteria not satisfied was inclusion of the word "Cochrane" in the co-publication title (50% adherence). The proportion adhering to a subset of criteria significantly increased for reviews published between 2013 and 2021 compared to those from 1998 to 2012. Compared to corresponding Cochrane reviews, there was no significant difference in the number of citations of co-publications across all sampled databases, although co-publication citations were usually less than those of original reviews.

CONCLUSION

Approximately one in four urology-related Cochrane reviews are co-published. Though co-publications garnered a considerable number of citations that could help in the dissemination of Cochrane reviews, many are not readily identifiable as such.

摘要

引言

Cochrane系统评价被广泛认为是权威的证据来源。为了提高传播范围和影响力,编辑团队经常鼓励在其他期刊上共同发表他们的评价。我们的研究旨在分析与泌尿外科相关的共同发表情况,并使用引文分析确定其是否符合Cochrane的四项共同发表标准及其影响力。

方法

我们使用MEDLINE、Web of Science、Scopus和谷歌学术数据库,系统地识别了1998年至2021年期间泌尿外科、尿失禁、肾脏和移植小组发表的所有Cochrane评价以及随后的共同发表情况。我们还确定了是否符合Cochrane的四项共同发表标准,并分析了引用率。

结果

在纳入的202篇Cochrane评价中,52篇(25.7%)有相关的共同发表。大多数共同发表对应于泌尿外科小组(39篇;76.9%),其次是尿失禁小组(9篇;17.3%)和肾脏与移植小组(3篇;5.8%)。只有21篇(40.0%)共同发表符合所有四项共同发表标准,最常未满足的标准是共同发表标题中包含“Cochrane”一词(符合率为50%)。与1998年至2012年发表的评价相比,2013年至2021年发表的评价符合部分标准的比例显著增加。与相应的Cochrane评价相比,所有抽样数据库中共同发表的引用次数没有显著差异,尽管共同发表的引用次数通常少于原始评价。

结论

大约四分之一与泌尿外科相关的Cochrane评价是共同发表的。虽然共同发表获得了相当数量的引用,这有助于Cochrane评价的传播,但许多共同发表并不容易被识别出来。

相似文献

1
Criteria adherence and citation impact of urologic Cochrane review co-publications.泌尿外科Cochrane系统评价共同发表文献的标准依从性和引用影响力。
Cochrane Evid Synth Methods. 2023 Mar 27;1(2):e12004. doi: 10.1002/cesm.12004. eCollection 2023 Apr.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Cochrane systematic reviews and co-publication: dissemination of evidence on interventions for ophthalmic conditions.考科蓝系统评价与共同发表:眼科疾病干预措施证据的传播
Syst Rev. 2015 Sep 22;4:118. doi: 10.1186/s13643-015-0104-5.
4
Citation of updated and co-published Cochrane Methodology Reviews.引用更新的和共同发表的 Cochrane 方法学评论。
Syst Rev. 2023 Jul 14;12(1):120. doi: 10.1186/s13643-023-02270-w.
5
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
6
Predatory publishing or a lack of peer review transparency?-a contemporary analysis of indexed open and non-open access articles in paediatric urology.掠夺性出版还是缺乏同行评审透明度?-小儿泌尿外科索引开放和非开放获取文章的当代分析。
J Pediatr Urol. 2019 Apr;15(2):159.e1-159.e7. doi: 10.1016/j.jpurol.2018.08.019. Epub 2019 Feb 15.
7
Defining the publication source of high-quality evidence in urology: an analysis of EvidenceUpdates.界定泌尿外科高质量证据的出版来源:对“证据更新”的分析
BJU Int. 2016 Jun;117(6):861-6. doi: 10.1111/bju.13392. Epub 2016 Jan 9.
8
Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals.对发表在普通医学期刊上的文章在科学网、Scopus和谷歌学术中被引用情况的比较。
JAMA. 2009 Sep 9;302(10):1092-6. doi: 10.1001/jama.2009.1307.
9
Bibliometric Analysis of Erectile Dysfunction Publications in Urology and Sexual Medicine Journals.泌尿学和性医学期刊中勃起功能障碍文献的计量分析。
J Sex Med. 2018 Oct;15(10):1426-1433. doi: 10.1016/j.jsxm.2018.08.004. Epub 2018 Sep 12.
10
A descriptive study found low prevalence of presumed predatory publications in a subset of Cochrane reviews.一项描述性研究发现,在 Cochrane 综述的一个子集中,假定掠夺性出版物的出现率较低。
J Clin Epidemiol. 2022 Dec;152:316-325. doi: 10.1016/j.jclinepi.2022.09.004. Epub 2022 Sep 14.

本文引用的文献

1
Copublication improved the dissemination of Cochrane reviews and benefited copublishing journals: a retrospective cohort study.共同发表提高了 Cochrane 综述的传播,并使共同发表的期刊受益:一项回顾性队列研究。
J Clin Epidemiol. 2022 Sep;149:110-117. doi: 10.1016/j.jclinepi.2022.05.016. Epub 2022 May 30.
2
Low Methodological Quality of Systematic Reviews Published in the Urological Literature (2016-2018).2016-2018 年发表的泌尿外科学文献中的系统评价方法学质量较低。
Urology. 2020 Apr;138:5-10. doi: 10.1016/j.urology.2020.01.004. Epub 2020 Jan 15.
3
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
AMSTAR 2:一种用于系统评价的关键评估工具,该系统评价包括医疗保健干预措施的随机或非随机研究,或两者皆有。
BMJ. 2017 Sep 21;358:j4008. doi: 10.1136/bmj.j4008.
4
The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.泌尿外科系统评价的概况(1998年至2015年):方法学质量评估
BJU Int. 2017 Apr;119(4):638-649. doi: 10.1111/bju.13653. Epub 2016 Oct 17.
5
Cochrane systematic reviews and co-publication: dissemination of evidence on interventions for ophthalmic conditions.考科蓝系统评价与共同发表:眼科疾病干预措施证据的传播
Syst Rev. 2015 Sep 22;4:118. doi: 10.1186/s13643-015-0104-5.
6
Methodological Quality of Systematic Reviews Published in the Urological Literature from 1998 to 2012.1998年至2012年发表于泌尿学文献中的系统评价的方法学质量
J Urol. 2015 Nov;194(5):1374-9. doi: 10.1016/j.juro.2015.05.085. Epub 2015 May 27.
7
Assessment of the methodological quality of systematic reviews published in the urological literature from 1998 to 2008.评估 1998 年至 2008 年泌尿外科学文献中发表的系统评价的方法学质量。
J Urol. 2010 Aug;184(2):648-53. doi: 10.1016/j.juro.2010.03.127. Epub 2010 Jun 19.
8
Evidence-based urology in practice: the Cochrane Library.实践中的循证泌尿外科:考克兰图书馆
BJU Int. 2009 Oct;104(8):1048-9. doi: 10.1111/j.1464-410X.2009.08749.x. Epub 2009 Jul 7.
9
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.AMSTAR的开发:一种评估系统评价方法学质量的测量工具。
BMC Med Res Methodol. 2007 Feb 15;7:10. doi: 10.1186/1471-2288-7-10.